Streetbeat News

Regulatory

TNON

Tenon Medical, Inc. (TNON) announced the issuance of a Notice of Allowance from the USPTO for a patent application enhancing claims for its Catamaran SI Joint implant. This addition to Tenon's patent portfolio, which includes 8 issued patents and 23 pending applications, underscores the company's commitment to protecting its innovative sacroiliac joint treatment technologies.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:13 pm

BABA

JD

LI

NTES

Hong Kong stocks, particularly the Hang Seng Index (HSI), are entering the year of the dragon with historical optimism, given the index's average gain of 14% in past dragon years. However, uncertainties such as the U.S. presidential election and interest rate policy may affect the rally. Positive signs include China's economic stimulus and foreign investment in Chinese companies like Alibaba, Li Auto, JD.com, and NetEase. Major investment banks predict varied HSI performance, with potential impacts from U.S.-China relations and global geopolitics. Analysts advise cautious investment, favoring stocks with a strong mainland focus or those undervalued, like Alibaba.

Portfolio Pulse from The Bamboo Works

February 22, 2024 | 1:10 pm

MDAI

Spectral AI, Inc. (NASDAQ:MDAI) has received UKCA authorization for its DeepView AI-Burn software, enabling the sale of its DeepView System in the UK for burn wound diagnosis. The company plans to deploy six devices in the UK for customer evaluation and expects to generate revenue in H2 2024. This authorization also facilitates expansion into the Middle East. The DeepView System, with a 92% accuracy rate, significantly improves upon the current standard of care for assessing burn wounds, which has a 50% to 75% accuracy rate.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:03 pm

ICU

Seastar Medical Holding has received FDA approval for its Selective Cytopheretic Device (SCD) Pediatric for use in children weighing 10 kilograms or more with acute kidney injury due to sepsis or a septic condition requiring kidney replacement therapy. This approval marks a significant milestone for the company, potentially opening up new markets and enhancing its product portfolio in the medical device sector.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:56 pm

BZFD

NVDA

RIVN

NVIDIA Corporation (NASDAQ:NVDA) shares surged 14.3% in pre-market trading after reporting Q4 financial results that exceeded expectations and provided strong Q1 revenue guidance. Other stocks also moved significantly in pre-market trading, with notable gainers including Agile Therapeutics, BuzzFeed, and Elevai Labs, among others. On the losing side, Draganfly, Synaptogenix, and Bel Fuse experienced significant drops following various announcements.

Portfolio Pulse from Avi Kapoor

February 22, 2024 | 12:55 pm

SVFD

Save Foods Inc. has announced that its subsidiary, NTwo Off, has filed a U.S. patent application for a technology aimed at reducing greenhouse gas emissions in wheat production. This innovation could significantly impact sustainability practices in agriculture, aligning with global efforts to combat climate change.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:50 pm

ZBH

Zimmer Biomet announced FDA clearance for its ROSA Shoulder System, marking it as the first robotic surgical assistant for shoulder arthroplasty. This achievement represents the fourth ROSA Robotics application cleared in five years, highlighting Zimmer Biomet's innovation in robotic-assisted surgeries.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:38 pm

VERO

Venus Concept announced receiving the CE Mark from DEKRA Certification B.V., enabling the marketing of Venus Versa Pro in Europe. This certification is a significant step for Venus Concept, allowing it to expand its market presence in Europe.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:36 pm

ELEV

Elevation Oncology has expanded its Phase 1 clinical trial of EO-3021 to include Japan, marking the first international patient dosing outside the United States. This expansion signifies a significant step in the global development of EO-3021, potentially impacting the company's valuation and investor interest.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:35 pm

NVDA

QQQ

SPY

Nvidia's impressive earnings report has sparked optimism in the market, leading to a jump in Nasdaq and S&P 500 futures. Investors are now focused on upcoming economic data, including jobless claims and Fed speeches, to gauge the market's direction. Other stocks mentioned include Five9, Lucid Group, Rivian Automotive, Sunnova Energy, and Sunrun, which moved on their earnings reports. Additionally, several companies are set to report their quarterly results.

Portfolio Pulse from Shanthi Rexaline

February 22, 2024 | 12:23 pm